April Davis

1.5k total citations · 1 hit paper
10 papers, 996 citations indexed

About

April Davis is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, April Davis has authored 10 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in April Davis's work include Cancer Cells and Metastasis (3 papers), RNA modifications and cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). April Davis is often cited by papers focused on Cancer Cells and Metastasis (3 papers), RNA modifications and cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). April Davis collaborates with scholars based in United States, South Korea and Georgia. April Davis's co-authors include Max S. Wicha, Shawn G. Clouthier, Tahra Luther, Hasan Körkaya, Khaled A. Hassan, Suling Liu, Ahmed A. Quraishi, Rosemarie C. D'Angelo, Amanda K. Paulson and Susan Chung and has published in prestigious journals such as Molecular Cell, Cell Metabolism and Cancer Research.

In The Last Decade

April Davis

10 papers receiving 987 citations

Hit Papers

Activation of an IL6 Inflammatory Loop Mediates Trastuzum... 2012 2026 2016 2021 2012 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
April Davis United States 6 634 617 316 133 97 10 996
Vera Levina United States 13 688 1.1× 581 0.9× 296 0.9× 178 1.3× 141 1.5× 18 1.1k
Stefanie Tiede Switzerland 9 455 0.7× 536 0.9× 312 1.0× 105 0.8× 115 1.2× 9 936
Ángel Santiago Mexico 9 325 0.5× 697 1.1× 261 0.8× 137 1.0× 69 0.7× 16 908
Alysha K. Croker Canada 5 748 1.2× 501 0.8× 359 1.1× 77 0.6× 103 1.1× 5 1.0k
Claudia P. Miller United States 16 364 0.6× 722 1.2× 185 0.6× 143 1.1× 84 0.9× 23 1.1k
Ramesh Butti India 12 352 0.6× 545 0.9× 315 1.0× 113 0.8× 90 0.9× 19 921
Hye Gyeong Park South Korea 12 310 0.5× 531 0.9× 361 1.1× 85 0.6× 126 1.3× 12 888
Sarah J. Conley United States 7 553 0.9× 655 1.1× 497 1.6× 91 0.7× 84 0.9× 13 1.1k
Amanda K. Paulson United States 6 1.0k 1.6× 798 1.3× 368 1.2× 163 1.2× 116 1.2× 8 1.4k
Rosemarie C. D'Angelo United States 5 497 0.8× 391 0.6× 205 0.6× 131 1.0× 55 0.6× 5 708

Countries citing papers authored by April Davis

Since Specialization
Citations

This map shows the geographic impact of April Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April Davis more than expected).

Fields of papers citing papers by April Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by April Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April Davis. The network helps show where April Davis may publish in the future.

Co-authorship network of co-authors of April Davis

This figure shows the co-authorship network connecting the top 25 collaborators of April Davis. A scholar is included among the top collaborators of April Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with April Davis. April Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wang, Luo, April Davis, Hasan Körkaya, et al.. (2018). The EGFR T790M Mutation Is Acquired through AICDA-Mediated Deamination of 5-Methylcytosine following TKI Treatment in Lung Cancer. Cancer Research. 78(24). 6728–6735. 25 indexed citations
2.
Luo, Ming, Shang Li, Michael Brooks, et al.. (2018). Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling. Cell Metabolism. 28(1). 69–86.e6. 275 indexed citations
3.
Hassan, Khaled A., et al.. (2017). Abstract 4119: The development of EGFR resistant mutation, T790M, in lung adenocarcinoma is acquired through a specific cytosine deamination mechanism. Cancer Research. 77(13_Supplement). 4119–4119. 1 indexed citations
4.
Liu, Yajing, Monika L. Burness, Rachel Martin-Trevino, et al.. (2016). RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer. Clinical Cancer Research. 23(2). 514–522. 123 indexed citations
5.
Zhong, Haihong, April Davis, Maria Ouzounova, et al.. (2016). A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors. Cancer Research. 76(2). 480–490. 40 indexed citations
6.
D'Angelo, Rosemarie C., Maria Ouzounova, April Davis, et al.. (2015). Notch Reporter Activity in Breast Cancer Cell Lines Identifies a Subset of Cells with Stem Cell Activity. Molecular Cancer Therapeutics. 14(3). 779–787. 98 indexed citations
7.
Liu, Yajing, Rachel Martin-Trevino, Shang Li, et al.. (2015). Abstract 4226: Histone deacetylase inhibitors sensitize cancer stem cells to PARP inhibitors in triple-negative breast cancer. Cancer Research. 75(15_Supplement). 4226–4226. 5 indexed citations
8.
Luo, Ming, April Davis, Sean McDermott, et al.. (2015). Abstract 2311: Targeting EMT and MET breast cancer stem cell states through simultaneous inhibition of glycolytic and antioxidant pathways. Cancer Research. 75(15_Supplement). 2311–2311. 1 indexed citations
9.
Körkaya, Hasan, April Davis, Fayaz Malik, et al.. (2012). Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population. Molecular Cell. 47(4). 570–584. 427 indexed citations breakdown →
10.
Hassan, Khaled A., Luo Wang, Gwangil Kim, et al.. (2012). Abstract 3309: Blocking the Notch pathway inhibits the epithelial-mesenchymal transition (EMT) status in lung cancer and alters chemoresistance. Cancer Research. 72(8_Supplement). 3309–3309. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026